Trial Watch: Toll-like receptor agonists in cancer immunotherapy

by Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2018-12-01

DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway

by Danfeng Sun, Weichao Wang, Fangfang Guo, Michael R. Pitter, Wan Du, Shuang Wei, Sara Grove, Linda Vatan, Yingxuan Chen, Ilona Kryczek, Eric R. Fearon, Jing-Yuan Fang, Weiping Zou
Published 2022-12-01